StockData

Lantheus vs QuidelOrtho

LNTH and QDEL side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How LNTH and QDEL compare

Lantheus is the larger company, worth 9.5 times as much as QuidelOrtho ($6.6B against $700M).

Lantheus grew revenue faster over the last twelve months (2.3% versus −4.5% for QuidelOrtho).

Lantheus keeps more of each dollar of sales as profit, with a net margin of 17.7% compared with −14.2% at QuidelOrtho.

Lantheus scores higher on the StockData Score (11 against 6 for QuidelOrtho), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricLNTHQDEL
Size and price
Market cap$6.6B$700M
Share price$101.72$10.21
Change, 1 year91.5%−54.0%
Change, 5 years265%−92.9%
Beta (5Y)0.411.27
Employees1,1936,500
StockData Score
Total score11 (better)6
Valuation score03 (better)
Growth score2 (better)0
Performance score5 (better)2
Health score4 (better)1
Dividend score00
Valuation
P/E24.6×–
P/S4.3×0.3× (better)
P/B5.1×0.4× (better)
EV/EBITDA16.9×10.4× (better)
PEG0.24–
FCF yield–−16.7%
Fair value$91.21$26.84
Margin of safety−11.5%62.0% (better)
Growth
Revenue growth (TTM)2.3% (better)−4.5%
Revenue growth, 5Y average35.3% (better)10.4%
Net income growth (TTM)1.6%–
EPS growth (TTM)9.5%–
Profitability
Gross margin60.1% (better)44.2%
Operating margin19.4% (better)−4.9%
Net margin17.7% (better)−14.2%
FCF margin–−4.5%
Return on equity22.2% (better)−19.3%
Return on invested capital19.7% (better)−2.2%
Financial health
Debt / equity0.44 (better)1.64
Net debt / EBITDA−0.068.29 (better)
Interest coverage15.3× (better)−0.6×
Current ratio3.06 (better)1.36
Altman Z-score5.52 (better)0.26
Piotroski F-score56 (better)
Dividends and buybacks
Buyback yield–−0.64%
Shareholder yield0.00% (better)−0.64%
Ownership
Held by institutions117%121%
Held by insiders2.3%43.4%
Insider net buying, 12 months–$669K
Short interest, % of float5.7%37.3%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.